Canopy Growth Corp vs ProShares Ultra Gold ETF — how do they compare? Canopy Growth Corp trades at $0.97 (market cap $398.46M), while ProShares Ultra Gold ETF trades at $44.56. The key difference: ProShares Ultra Gold ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | UGL | |
|---|---|---|
Market Cap | $398.46M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.92 | $85.62 |
52-Week Low | $0.86 | $33.59 |
Enterprise Value | $337.90M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
UGL trades at $43.38, down 5.2% over 24 hours amid a bearish technical outlook with 19 sell signals versus 2 buys. The stock faces resistance at $44 and $45, with support at $43 and $42. Financial ratios are unavailable, limiting fundamental clarity. Recent news highlights gold market volatility, with prices influenced by Fed policy, inflation data, and geopolitical tensions, though UGL's direct exposure is not detailed.
The outlook remains cautious due to weak technical momentum and lack of financial data. Risks include gold price sensitivity to interest rates and macroeconomic shifts. Investors should await earnings reports for fundamental validation, as current analysis relies heavily on technical indicators and broader sector sentiment.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →